
I graduated in Psychology at University Jaume I (Castellón, Spain) in 2010/11. After getting my MSc in Clinical Psychology, Health and Neuropsychology at the same university, I got my PhD in Behavioral Neuroscience/Psychology. During my PhD, my research was focused on the study of the role of dopamine and the effect of physical exercise on anergia or lack of motivation in animal models as a symptom of depression. I was also involved in drug addiction studies focused on understanding how the combination of drugs (e.g.alcohol and caffeine) interact in the brain and affect behavior.
After my PhD, I worked as a Research Associate at the University of Cambridge. There, I contributed to the development of translational cognitive tasks designed to assess motivation and affective state in mice using touchscreen-based devices. I also worked on a GSK-funded project examining the potential effects of stress-induced inflammation on depression development and vulnerability. Additionally, I collaborated on research into neurodegenerative diseases, including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis–frontotemporal dementia (ALS–FTD) models.
Currently, my research focuses on the study of individual differences in cognitive affective biases and vulnerability to depression both in humans and rodents and on the development of new translational tests for assessing depression. However, my interests and expertise are not limited to the study of affective state but to any other cognitive domain that can be affected across several psychopathologies, drug screenings, and behavioral phenotyping.
Internal Collaborators